Virchows Archiv

, Volume 443, Issue 1, pp 38–43

Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours

  • Raffaèle Fauvet
  • Christophe Poncelet
  • Danièle Hugol
  • Anne Lavaur
  • Gérard Feldmann
  • Emile Daraï
Original Article

Abstract

Apoptosis is a physiological process by which multicellular organisms eliminate superfluous cells. Alterations in apoptosis play a key role in tumour development. The objective was to evaluate the immunohistochemical expression of p53, p21, bax, bak, fas, bcl-2 and bcl-x proteins in 10 endometriomas, 20 benign ovarian tumours (10 mucinous, 10 serous) and 30 malignant ovarian tumours (9 mucinous, 19 serous; 2 endometrioids). p53 positive cells (mean±SD) in endometriomas, and benign and malignant tumours were 1.9±3.2, 0 and 16.2±33.0, respectively. The difference was significant between benign tumours and endometriomas (P=0.003) but not between endometriomas and malignant tumours. P21 expression in endometriomas and benign and malignant tumours was 19.5±27.8, 1.7±6.7 and 4.1±8.6, respectively. Increased p21 expression was found in endometriomas compared with benign (P=0.001) and malignant (P=0.01) tumours. Bax expression was higher in endometriomas than in benign tumours (P=0.01), but no difference was found between endometriomas and malignant tumours. No difference in bak, fas, bcl-2 or bcl-x expression was observed among the groups. In endometriomas, a negative correlation was found between p53 and fas expression (P=0.04, r=0.66). Although endometriomas have histological features of benign ovarian tumours, endometriomas share with malignant ovarian tumours certain alterations in apoptosis-related proteins.

Keywords

Apoptosis Endometriomas Ovarian tumours Ovarian cancer 

References

  1. 1.
    Athanassiadou P, Petrakakou E, Sakelariou V, Zerva C, Liossi A, Michalas S, Athanassiades P (1998) Expression of p53, bcl-2 and heat shock protein (hsp72) in malignant and benign ovarian tumours. Eur J Cancer Prev 7:225–231PubMedGoogle Scholar
  2. 2.
    Attardi LD, Lowe SW, Brugarolas J, Jacks T (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J 15:3693–3701Google Scholar
  3. 3.
    Bayramoglu H, Duzcan E (2001) Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis. Pathol Oncol Res 7:33–38PubMedGoogle Scholar
  4. 4.
    Ben-Hur H, Gurevich P, Huszar M, et al (1999) Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: immunohistochemical and morphometric studies. Eur J Gynaecol Oncol 20:249–253PubMedGoogle Scholar
  5. 5.
    Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552–557Google Scholar
  6. 6.
    Chan WY, Cheung KK, Schorge JO, et al (2000) Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol 156:409–417PubMedGoogle Scholar
  7. 7.
    Chang CC, Hsieh YY, Tsai FJ, Tsai CH, Tsai HD, Lin CC (2002) The proline form of p53 codon 72 polymorphism is associated with endometriosis. Fertil Steril 77:43–45CrossRefPubMedGoogle Scholar
  8. 8.
    Darai E, Bringuier AF, Walker-Combrouze F, Feldmann G, Madelenat P, Scoazec JY (1998) Soluble adhesion molecules in serum and cysts fluids from patients with cystic tumours of the ovary. Hum Reprod 13:2831–2835CrossRefPubMedGoogle Scholar
  9. 9.
    Darai E, Leblanc M, Walker-Combrouze F, Bringuier AF, Madelenat P, Scoazec JY (1998) Expression of cadherins and CD44 isoforms in ovarian endometrial cysts. Hum Reprod 13:1346–1352PubMedGoogle Scholar
  10. 10.
    Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675–684PubMedGoogle Scholar
  11. 11.
    Gottlieb TM, Oren M (1998) p53 and apoptosis. Semin Cancer Biol 8:359–368CrossRefPubMedGoogle Scholar
  12. 12.
    Goumenou A, Panayiotides I, Matalliotakis I, Vlachonikolis I, Tzardi M, and Koumantakis E (2001) Bcl-2 and Bax expression in human endometriotic and adenomyotic tissues. Eur J Obstet Gynecol Reprod Biol 99:256–260CrossRefPubMedGoogle Scholar
  13. 13.
    Harada M, Suganuma N, Furuhashi M, Nagasaka T, Nakashima N, Kikkawa F, Tomoda Y, Furui K (1996) Detection of apoptosis in human endometriotic tissues. Mol Hum Reprod 2:307–315PubMedGoogle Scholar
  14. 14.
    Heaps JM, Nieberg RK, Berek JS (1990) Malignant neoplasms arising in endometriosis. Obstet Gynecol 75:1023–1028PubMedGoogle Scholar
  15. 15.
    Hsieh YY, Tsai FJ, Chang CC, Chen WC, Tsai CH, Tsai HD, Lin CC (2001) p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis. J Clin Lab Anal 15:184–187CrossRefPubMedGoogle Scholar
  16. 16.
    Hsu SY, Hsueh AJ (2000) Tissue-specific Bcl-2 protein partners in apoptosis: an ovarian paradigm. Physiol Rev 80:593–614Google Scholar
  17. 17.
    International Federation of Gynecology and Obstetrics (1971) Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 50:1–7PubMedGoogle Scholar
  18. 18.
    Jenkins S, Olive DL, Haney AF (1986) Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol 67:335–338PubMedGoogle Scholar
  19. 19.
    Jones RK, Searle RF, Bulmer JN (1998) Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Hum Reprod 13:3496–3502CrossRefPubMedGoogle Scholar
  20. 20.
    Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMedGoogle Scholar
  21. 21.
    Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96–99PubMedGoogle Scholar
  22. 22.
    Kokawa K, Shikone T, Otani T, et al (2001) Apoptosis and the expression of bax and bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium. Hum Reprod 16:2211–2218CrossRefPubMedGoogle Scholar
  23. 23.
    Lebovic DI, Mueller MD, Taylor RN (2001) Immunobiology of endometriosis. Fertil Steril 75:1–10CrossRefPubMedGoogle Scholar
  24. 24.
    Marone M, Scambia G, Mozzetti S, et al (1998) Bcl-2, bax, bcl-xl, and bcl-xs expression in normal and neoplastic ovarian tissues. Clin Cancer Res 4:517–524PubMedGoogle Scholar
  25. 25.
    McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW (1997) Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci U S A 94:2345–2349CrossRefPubMedGoogle Scholar
  26. 26.
    McLaren J, Prentice A, Charnok-Jones DS, Sharkey AM, Smith SK (1997) Immunolocalization of the apoptosis regulating proteins bcl-2 and bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod 12:146–152PubMedGoogle Scholar
  27. 27.
    Meresman GF, Vighi S, Buquet RA, Contreras-Ortiz O, Tesone M, Rumi LS (2000) Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril 74:760–766CrossRefPubMedGoogle Scholar
  28. 28.
    Nagata S (1994) Fas and Fas ligand: a death factor and its receptor. Adv Immunol 57:129–144PubMedGoogle Scholar
  29. 29.
    Nakayama K, Toki T, Zhai YL, Lu X, Horiuchi A, Nikaido T, Konishi I, Fujii S (2001) Demonstration of focal p53 expression without genetic alterations in endometriotic lesions. Int J Gynecol Pathol 20:227–231PubMedGoogle Scholar
  30. 30.
    Nezhat FR, Kalir T (2002) Comparative immunohistochemical studies of endometriosis lesions and endometriotic cysts. Fertil Steril 78:820–824CrossRefPubMedGoogle Scholar
  31. 31.
    Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T (2002) Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 94:2935–2940CrossRefPubMedGoogle Scholar
  32. 32.
    Owen-Schaub LB, Zhang W, Cusack JC, et al (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15:3032–3040PubMedGoogle Scholar
  33. 33.
    Ridley JH (1968) The histogenesis of endometriosis. A review of facts and fancies. Obstet Gynecol 23:1–35Google Scholar
  34. 34.
    Ryan IP, Taylor RN (1997) Endometriosis and infertility: new concepts. Obstet Gynecol Surv 52:365–371CrossRefPubMedGoogle Scholar
  35. 35.
    Sampson JA (1927) Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:422–469Google Scholar
  36. 36.
    Schneider J, Jimenez E, Rodriguez F, del Tanago JG (1998) c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis. Oncol Rep 5:49–52PubMedGoogle Scholar
  37. 37.
    Stovall DW, Bowser LM, Archer DF, Guzick DS (1997) Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain. Fertil Steril 68:13–18CrossRefPubMedGoogle Scholar
  38. 38.
    Suganuma N, Harada M, Furuhashi M, Nawa A, Kikkawa F (1997) Apoptosis in human endometrial and endometriotic tissues. Horm Res 48:42–47PubMedGoogle Scholar
  39. 39.
    Vaux Dl, Cory S, Adams JM (1988) Bcl-2 gene promotes haematopoetic cell survival and co-operates with c-myc to immortalize pre-B cells. Nature 335:440–442PubMedGoogle Scholar
  40. 40.
    Vercellini P, Trespidi L, De Giorgi O (1996) Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril 65:299–304PubMedGoogle Scholar
  41. 41.
    Vogt J (1872) Untersuchungen uber die Entwicklungsgeschichte der Geburtshelferkroete (Alytes obstetricians). Jent & Gassman, Solothurn, SwitzerlandGoogle Scholar
  42. 42.
    Watanabe H, Kanzaki H, Narukawa S, Inoue T, Katsuragawa H, Kaneko Y, and Mori T (1997) Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol 176:360–368PubMedGoogle Scholar
  43. 43.
    Werness BA, Freedman AN, Piver MS, Romero-Gutierrez M, Petrow E (1999) Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary. Gynecol Oncol 75:413–418CrossRefPubMedGoogle Scholar
  44. 44.
    Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637–640PubMedGoogle Scholar
  45. 45.
    Zusman I, Gurevich P, Gurevich E, Ben-Hur H (2001) The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (a review). Int J Oncol 18:965–972PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Raffaèle Fauvet
    • 1
    • 2
  • Christophe Poncelet
    • 2
  • Danièle Hugol
    • 4
  • Anne Lavaur
    • 1
  • Gérard Feldmann
    • 2
  • Emile Daraï
    • 1
    • 2
    • 3
  1. 1.Service de GynécologieHôpital Hôtel-Dieu, AP-HPFrance
  2. 2.Laboratoire de biologie cellulaireINSERM U327, Faculté Bichat-Claude BernardFrance
  3. 3.Service de Gynécologie-ObstétriqueHôpital TenonParisFrance
  4. 4.Service d'Anatomie PathologieHôpital Hôtel-Dieu, AP-HPFrance

Personalised recommendations